Trials / Conditions / Refractory B Lymphoblastic Lymphoma
Refractory B Lymphoblastic Lymphoma
4 registered clinical trials studyying Refractory B Lymphoblastic Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphobl NCT03991884 | University of Washington | Phase 1 |
| Active Not Recruiting | Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblast NCT03504644 | ECOG-ACRIN Cancer Research Group | Phase 1 / Phase 2 |
| Withdrawn | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase NCT02538926 | University of Washington | Phase 2 |
| Recruiting | Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD2 NCT02981628 | Children's Oncology Group | Phase 2 |